SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sandy Feng, Jennifer C. Lai, Expanded Criteria Donors, Clinics in Liver Disease, 2014, 18, 3, 633

    CrossRef

  2. 2
    Elizabeth C. Verna, Hepatitis Viruses and Liver Transplantation, Clinics in Liver Disease, 2014, 18, 3, 575

    CrossRef

  3. 3
    Y. Ohno, A. Mita, T. Ikegami, Y. Masuda, K. Urata, Y. Nakazawa, A. Kobayashi, S. Miyagawa, Successful Active Immunization Using a Hepatitis B Virus Vaccination Protocol for a Recipient With Hepatitis B Core Antibody–Positive Liver Graft, Transplantation Proceedings, 2014, 46, 3, 721

    CrossRef

  4. 4
    M. Tufano, D. Liccardo, S. Riva, M. Candusso, G. Torre, R. Iorio, Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection, Transplant Infectious Disease, 2013, 15, 2
  5. 5
    Mario Angelico, Alessandra Nardi, Tania Marianelli, Lucio Caccamo, Renato Romagnoli, Giuseppe Tisone, Antonio D. Pinna, Alfonso W. Avolio, Stefano Fagiuoli, Patrizia Burra, Mario Strazzabosco, Alessandro Nanni Costa, Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study, Journal of Hepatology, 2013, 58, 4, 715

    CrossRef

  6. 6
    Matthew S. Chang, Sonja K. Olsen, Elsa M. Pichardo, Jessica B. Stiles, Lori Rosenthal-Cogan, William D. Brubaker, James V. Guarrera, Jean C. Emond, Robert S. Brown, Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and Other Nucleos(t)ides, Transplantation Journal, 2013, 95, 7, 960

    CrossRef

  7. 7
    Payam Dindoost, Seyed Mohammad Jazayeri, Seyed Moayed Alavian, Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update, Hepatitis Monthly, 2012, 12, 3, 168

    CrossRef

  8. 8
    Malcolm P. MacConmara, Neeta Vachharajani, Jason R. Wellen, Christopher D. Anderson, Jeffrey A. Lowell, Surendra Shenoy, William C. Chapman, Maria B. Majella Doyle, Utilization of hepatitis B core antibody-positive donor liver grafts, HPB, 2012, 14, 1
  9. 9
    Corinne Buchanan, Tram T. Tran, Current Status of Liver Transplantation for Hepatitis B Virus, Clinics in Liver Disease, 2011, 15, 4, 753

    CrossRef

  10. 10
    Jen-Jung Pan, Nirav Thosani, Victor I. Machicao, Michael B. Fallon, Current use of hepatitis B immune globulin for prevention of de novo hepatitis B in recipients receiving anti-HBc-positive livers, Hepatology International, 2011, 5, 2, 635

    CrossRef

  11. 11
    V. Scuderi, A. Ceriello, W. Santaniello, G. Aragiusto, M. Romano, C. Migliaccio, F. Calise, Hepatitis B Prophylaxis in Hepatitis B–Negative Recipients Transplanted With Donor Grafts Positive for Hepatitis B Core Antibodies, Transplantation Proceedings, 2011, 43, 1, 271

    CrossRef

  12. 12
    Q. Lai, A. Molinaro, G. Spoletini, G. Mennini, M. Grieco, M. Merli, S.G. Corradini, P.B. Berloco, M. Rossi, Impact of Anti-Hepatitis B Core-Positive Donors in Liver Transplantation: A Survival Analysis, Transplantation Proceedings, 2011, 43, 1, 274

    CrossRef

  13. You have free access to this content13
    Guy N. Brock, Farida Mostajabi, Nicole Ferguson, Christopher J. Carrubba, Mary Eng, Joseph F. Buell, Michael R. Marvin, Prophylaxis against de novo hepatitis B for liver transplantation utilizing hep B core (+) donors: does hepatitis B immunoglobulin provide a survival advantage?, Transplant International, 2011, 24, 6
  14. 14
    Catherine L. Skagen, Janice H. Jou, Adnan Said, Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts – a systematic analysis, Clinical Transplantation, 2011, 25, 3
  15. 15
    Akihiro Nasu, Hiroyuki Marusawa, Yoshihide Ueda, Yuji Eso, Makoto Umeda, Tsutomu Chiba, Yukio Osaki, De novo hepatitis B virus infection in hepatocellular carcinoma following eradication of hepatitis C virus by interferon therapy, Hepatology Research, 2010, 40, 6
  16. 16
    Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs, Liver grafts from anti-hepatitis B core positive donors: A systematic review, Journal of Hepatology, 2010, 52, 2, 272

    CrossRef

  17. 17
    Vivian Iida Avelino-Silva, Luiz Augusto Carneiro D′Albuquerque, Patrícia Rodrigues Bonazzi, Alice Tung Wan Song, João Luiz Miraglia, Alan De Brito Neves, Edson Abdala, Liver transplant from Anti-HBc-positive, HBsAg-negative donor into HBsAg-negative recipient: is it safe? A systematic review of the literature, Clinical Transplantation, 2010, 24, 6
  18. 18
    Watcharasak Chotiyaputta, Shawn J. Pelletier, Robert J. Fontana, Anna S. F. Lok, Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers, Hepatology International, 2010, 4, 4, 707

    CrossRef

  19. 19
    Hui-Hui Tan, Paul Martin, Management of End-Stage Liver Disease in Chronic Hepatitis B, Clinics in Liver Disease, 2010, 14, 3, 477

    CrossRef

  20. 20
    Elisabetta Loggi, Florian Bihl, John V. Chisholm, Maurizio Biselli, Andrea Bontadini, Giovanni Vitale, Giorgio Ercolani, Gian Luca Grazi, Antonio D. Pinna, Mauro Bernardi, Christian Brander, Pietro Andreone, Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft, Journal of Hepatology, 2009, 50, 3, 625

    CrossRef

  21. 21
    Jay H. Hoofnagle, Reactivation of hepatitis B, Hepatology, 2009, 49, S5
  22. 22
    Lei Yu, Thomas Koepsell, Lisa Manhart, George Ioannou, Survival after orthotopic liver transplantation: The impact of antibody against hepatitis B core antigen in the donor, Liver Transplantation, 2009, 15, 10
  23. 23
    Jae Berm Park, Choon Hyuck David Kwon, Kwang-Woong Lee, Gyu-Seong Choi, Doo-Jin Kim, Jeong-Min Seo, Sung-Joo Kim, Jae-Won Joh, Suk-Koo Lee, Hepatitis B virus vaccine switch program for prevention of de novo hepatitis B virus infection in pediatric patients, Transplant International, 2008, 21, 4
  24. You have free access to this content24
    Koji Hashimoto, Charles Miller, The use of marginal grafts in liver transplantation, Journal of Hepato-Biliary-Pancreatic Surgery, 2008, 15, 2
  25. 25
    C.-C. Lin, C.-L. Chen, A. Concejero, C.-C. Wang, S.-H. Wang, Y.-W. Liu, C.-H. Yang, C.-C. Yong, T.-S. Lin, B. Jawan, Y.-F. Cheng, H.-L. Eng, Active Immunization to Prevent De Novo Hepatitis B Virus Infection in Pediatric Live Donor Liver Recipients, American Journal of Transplantation, 2007, 7, 1
  26. 26
    Richard Foster, Michael Zimmerman, James F. Trotter, Expanding Donor Options: Marginal, Living, and Split Donors, Clinics in Liver Disease, 2007, 11, 2, 417

    CrossRef

  27. 27
    Yuji Soejima, Toru Ikegami, Akinobu Taketomi, Tomoharu Yoshizumi, Hideaki Uchiyama, Noboru Harada, Yoichi Yamashita, Yoshihiko Maehara, Hepatitis B vaccination after living donor liver transplantation, Liver International, 2007, 27, 7
  28. 28
    Nobuyuki Takemura, Yasuhiko Sugawara, Sumihito Tamura, Masatoshi Makuuchi, Liver Transplantation Using Hepatitis B Core Antibody−Positive Grafts: Review and University of Tokyo Experience, Digestive Diseases and Sciences, 2007, 52, 10, 2472

    CrossRef

  29. 29
    A. Celebi Kobak, Z. Karasu, M. Kilic, T. Ozacar, F. Tekin, F. Gunsar, G. Ersoz, Y. Yuzer, Y. Tokat, Living Donor Liver Transplantation From Hepatitis B Core Antibody Positive Donors, Transplantation Proceedings, 2007, 39, 5, 1488

    CrossRef

  30. 30
    A. Marzano, E. Angelucci, P. Andreone, M. Brunetto, R. Bruno, P. Burra, P. Caraceni, B. Daniele, V. Di Marco, F. Fabrizi, S. Fagiuoli, P. Grossi, P. Lampertico, R. Meliconi, A. Mangia, M. Puoti, G. Raimondo, A. Smedile, Prophylaxis and treatment of hepatitis B in immunocompromised patients, Digestive and Liver Disease, 2007, 39, 5, 397

    CrossRef

  31. 31
    Juan F. Gallegos-Orozco, Hugo E. Vargas, Should Antihepatitis B Virus Core Positive or Antihepatitis C Virus Core Positive Subjects Be Accepted as Organ Donors for Liver Transplantation?, Journal of Clinical Gastroenterology, 2007, 41, 1, 66

    CrossRef

  32. 32
    Hugo Bonatti, Robert Sawyer, Rolland C Dickson, Raymond Razonable, Timothy Schmitt, Julio Mendez, Nina Singh, Timothy Pruett, Transmission of viral disease to the recipient through the donor liver, Current Opinion in Organ Transplantation, 2007, 12, 3, 231

    CrossRef

  33. 33
    R. D. Yen, H. Bonatti, J. Mendez, J. Aranda-Michel, R. Satyanarayana, R. C. Dickson, Case Report of Lamivudine-Resistant Hepatitis B Virus Infection Post Liver Transplantation from a Hepatitis B Core Antibody Donor, American Journal of Transplantation, 2006, 6, 5p1
  34. 34
    Chee-Kin Hui, Winnie WW Cheung, See-Ching Chan, Chung-Mau Lo, George KK Lau, Hepatitis B vaccination and preemptive treatment of hepatitis B virus in liver transplantation, Current Opinion in Organ Transplantation, 2006, 11, 6, 594

    CrossRef

  35. 35
    Emilia Prakoso, Simone I. Strasser, David J. Koorey, Deborah Verran, Geoffrey W. McCaughan, Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors, Clinical Transplantation, 2006, 20, 3
  36. 36
    Jose M. Nieto, Sammy Saab, Outcomes of liver transplantation using Hepatitis B core-positive liver grafts: Implications for prophylaxis, Current Hepatitis Reports, 2006, 5, 1, 33

    CrossRef

  37. 37
    D. MUTIMER, Review article: hepatitis B and liver transplantation, Alimentary Pharmacology & Therapeutics, 2006, 23, 8
  38. 38
    Dino Donataccio, Francine Roggen, Chantal Reyck, Catherine Verbaandert, Monique Bodeus, Jan Lerut, Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool, Transplant International, 2006, 19, 1
  39. 39
    Norah Terrault, Bruno Roche, Didier Samuel, Management of the hepatitis B virus in the liver transplantation setting: A European and an American perspective, Liver Transplantation, 2005, 11, 7
  40. 40
    Bruno Roche, Didier Samuel, Treatment of hepatitis�B and C after liver transplantation. Part 1, hepatitis�B, Transplant International, 2005,

    CrossRef

  41. 41
    Bruno Roche, Didier Samuel, Evolving strategies to prevent HBV recurrence, Liver Transplantation, 2004, 10, S10
  42. 42
    Bruno Roche, Didier Samuel, Treatment of hepatitis B and C after liver transplantation. Part 1, hepatitis B, Transplant International, 2004, 17, 12
  43. 43
    I. Villamil, A. Gonzalez-Quintela, A. Aguilera, S. Tome, E. Otero, F.J. Castroagudin, E. Varo, Truly de novo Hepatitis B After Liver Transplantation, The American Journal of Gastroenterology, 2004, 99, 4, 767

    CrossRef

  44. 44
    Juan Fernando Gallegos-Orozco, Hugo E. Vargas, Jorge Rakela, Virologically compromised donor grafts in liver transplantation, Journal of Hepatology, 2004, 41, 4, 512

    CrossRef

  45. 45
    Antonio López-Navidad, Francisco Caballero, Extended criteria for organ acceptance. Strategies for achieving organ safety and for increasing organ pool, Clinical Transplantation, 2003, 17, 4
  46. 46
    Vanessa H. de Villa, Yaw-Sen Chen, Chao-Long Chen, Hepatitis B core antibody-positive grafts: recipient???s risk, Transplantation, 2003, 75, Supplement, S49

    CrossRef

  47. 47
    Hector Rodriguez-Luna, Juan Arenas, Hugo E Vargas, The use of virologically compromised organs in liver transplantation, Clinics in Liver Disease, 2003, 7, 3, 573

    CrossRef

  48. 48
    Evangelos Cholongitas, George V Papatheodoridis, Management of HBV Infection and Liver Transplantation,